Conferences Spyre Therapeutics is attending in 2026
Spyre Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: ACT 2026 (on the program) and ACR Convergence 2026 (exhibiting). Spyre Therapeutics develops antibody-based therapies for inflammatory bowel disease and other chronic immune-mediated conditions. As of Nov 12, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
47th ACT Annual MeetingPharma & CRO nonclinical safety scientistsOfficial site |
San Antonio, TX ~1.4k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 2 posters
|
Open the guide Search and filter attendees |
ACR Convergence 2026Rheumatologists & autoimmune disease researchersOfficial site |
Past Orlando, FL ~15k attendees | ExhibitorAs published by American College of Rheumatology Booth 2933-CTProgram 2 posters
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 66 of the 162 conferences on our calendar, so this page shows Spyre Therapeutics’s involvement at those 66 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.